Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure

View source ↗

Summary

A clinical trial evaluating avatrombopag for thrombocytopenia in adults with chronic liver disease undergoing a procedure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• DOPTELET (avatrombopag)

Snippet

Sponsor: Sobi, Inc. | Conditions: Thrombocytopenia | Status: TERMINATED